Biohaven Ltd.

NYSE: BHVN · Healthcare · Biotechnology

PublicHQ New Haven, CT · New HavenCIK 0001935979Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH 24DQ —GM —SS 57

v0.1 · 35/100 weight · pillars only

↑ market scale, workforce scale · ↓ return on equity, listing tenure

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$738.8M

Employees

256

Market cap

$1.7B

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$738.8M-$738.8M2025

Operating income-$745.4M-$745.4M2025

Total assets$451.4M$451.4M2025

Liabilities$399.4M$399.4M2025

Equity$52.1M$52.1M2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Biohaven Ltd. earned -$738.8M in FY2025 net income.

Peers · Healthcare

Vir Biotechnology, Inc.49D Precigen, Inc.44D Aktis Oncology, Inc.——Recursion Pharmaceuticals, Inc.55C

Neighbors

New Haven →

Veradermics, Incorporated——Trevi Therapeutics, Inc.——Arvinas, Inc.$262.6M62C Rallybio Corporation$858.0k47D Precipio, Inc.$24.2M70B BioXcel Therapeutics, Inc.$642.0k27D

Key facts

CEOVladimir Coric

SectorHealthcare

IndustryBiotechnology

HeadquartersNew Haven, CT

ExchangeNYSE: BHVN

Employees256

IPO date2022-09-23

Latest filings

8-K2026-07-09 8-K2026-05-27 8-K2026-05-05 10-Q2026-05-04 8-K2026-05-04 8-K2026-05-04 DEF 14A2026-03-13 8-K2026-03-02

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.